{"id":"https://openalex.org/W2008189791","doi":"https://doi.org/10.4155/ppa.14.34","title":"New Spleen Tyrosine Kinase Inhibitors: Patent Applications Published During 2011\u20132013","display_name":"New Spleen Tyrosine Kinase Inhibitors: Patent Applications Published During 2011\u20132013","publication_year":2014,"publication_date":"2014-09-01","ids":{"openalex":"https://openalex.org/W2008189791","doi":"https://doi.org/10.4155/ppa.14.34","mag":"2008189791","pmid":"https://pubmed.ncbi.nlm.nih.gov/25374321"},"language":"en","primary_location":{"id":"doi:10.4155/ppa.14.34","doi":"https://doi.org/10.4155/ppa.14.34","is_oa":false,"landing_page_url":"https://doi.org/10.4155/ppa.14.34","pdf_url":null,"source":{"id":"https://openalex.org/S2764428516","display_name":"Pharmaceutical Patent Analyst","issn_l":"2046-8954","issn":["2046-8954","2046-8962"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Patent Analyst","raw_type":"journal-article"},"volume":null,"type":"review","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009025844","display_name":"Atli Thorarensen","orcid":"https://orcid.org/0000-0002-6791-5809","observed_orcids":["https://orcid.org/0000-0002-6791-5809"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Atli Thorarensen","raw_affiliation_strings":["Inflammation and Immunology Medicinal Chemistry, Pfizer Inc., 200 Cambridgepark Drive, Cambridge, MA 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation and Immunology Medicinal Chemistry, Pfizer Inc., 200 Cambridgepark Drive, Cambridge, MA 02140, USA","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5112579198","display_name":"Neelu Kaila","orcid":"https://orcid.org/0009-0002-4782-0789","observed_orcids":["https://orcid.org/0009-0002-4782-0789"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neelu Kaila","raw_affiliation_strings":["Inflammation and Immunology Medicinal Chemistry, Pfizer Inc., 200 Cambridgepark Drive, Cambridge, MA 02140, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Inflammation and Immunology Medicinal Chemistry, Pfizer Inc., 200 Cambridgepark Drive, Cambridge, MA 02140, USA","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I180857899"],"apc_list":null,"apc_paid":null,"fwci":0.5423,"has_fulltext":false,"cited_by_count":8,"citation_normalized_percentile":{"value":0.64285714,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":97},"biblio":{"volume":"3","issue":"5","first_page":"523","last_page":"541"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10856","display_name":"Intellectual Property and Patents","score":0.5990999937057495,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T10856","display_name":"Intellectual Property and Patents","score":0.5990999937057495,"subfield":{"id":"https://openalex.org/subfields/1405","display_name":"Management of Technology and Innovation"},"field":{"id":"https://openalex.org/fields/14","display_name":"Business, Management and Accounting"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10211","display_name":"Computational Drug Discovery Methods","score":0.19089999794960022,"subfield":{"id":"https://openalex.org/subfields/1703","display_name":"Computational Theory and Mathematics"},"field":{"id":"https://openalex.org/fields/17","display_name":"Computer Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10169","display_name":"Protein Kinase Regulation and GTPase Signaling","score":0.02370000071823597,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/syk","display_name":"Syk","score":0.9940000176429749},{"id":"https://openalex.org/keywords/syk-inhibitors","display_name":"SYK inhibitors","score":0.9929999709129333},{"id":"https://openalex.org/keywords/patent-applications","display_name":"patent applications","score":0.7129999995231628},{"id":"https://openalex.org/keywords/small-molecule-kinase-inhibitors","display_name":"small-molecule kinase inhibitors","score":0.8029999732971191},{"id":"https://openalex.org/keywords/inflammatory-diseases","display_name":"inflammatory diseases","score":0.7379999756813049},{"id":"https://openalex.org/keywords/drug-development","display_name":"drug development","score":0.4059999883174896}],"concepts":[{"id":"https://openalex.org/C90059517","wikidata":"https://www.wikidata.org/wiki/Q423572","display_name":"Bruton's tyrosine kinase","level":4,"score":0.6546599268913269},{"id":"https://openalex.org/C42362537","wikidata":"https://www.wikidata.org/wiki/Q87099740","display_name":"Tyrosine kinase","level":3,"score":0.6522974371910095},{"id":"https://openalex.org/C2780931953","wikidata":"https://www.wikidata.org/wiki/Q9371","display_name":"Spleen","level":2,"score":0.5304257869720459},{"id":"https://openalex.org/C2776165026","wikidata":"https://www.wikidata.org/wiki/Q188017","display_name":"Tyrosine","level":2,"score":0.46607136726379395},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.44446682929992676},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.4007628858089447},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3894154727458954},{"id":"https://openalex.org/C70721500","wikidata":"https://www.wikidata.org/wiki/Q177005","display_name":"Computational biology","level":1,"score":0.3851093053817749},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3681510090827942},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.276081919670105},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.24507620930671692},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.20103317499160767},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.1250353455543518}],"mesh":[{"descriptor_ui":"D000072377","descriptor_name":"Syk Kinase","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004345","descriptor_name":"Drug Industry","qualifier_ui":"Q000331","qualifier_name":"legislation & jurisprudence","is_major_topic":true},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010330","descriptor_name":"Patents as Topic","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D011505","descriptor_name":"Protein-Tyrosine Kinases","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D015394","descriptor_name":"Molecular Structure","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017277","descriptor_name":"Drug Approval","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D047428","descriptor_name":"Protein Kinase Inhibitors","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":true},{"descriptor_ui":"D047908","descriptor_name":"Intracellular Signaling Peptides and Proteins","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.4155/ppa.14.34","doi":"https://doi.org/10.4155/ppa.14.34","is_oa":false,"landing_page_url":"https://doi.org/10.4155/ppa.14.34","pdf_url":null,"source":{"id":"https://openalex.org/S2764428516","display_name":"Pharmaceutical Patent Analyst","issn_l":"2046-8954","issn":["2046-8954","2046-8962"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","poland-40","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320316","host_organization_name":"Future Science Ltd","host_organization_lineage":["https://openalex.org/P4310320316"],"host_organization_lineage_names":["Future Science Ltd"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical Patent Analyst","raw_type":"journal-article"},{"id":"pmid:25374321","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/25374321","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmaceutical patent analyst","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.4043000042438507,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"sustainable_development_goals_aurora":[{"score":0.5,"id":"https://metadata.un.org/sdg/4","display_name":"Quality education"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":14,"referenced_works":["https://openalex.org/W1880574679","https://openalex.org/W1971155911","https://openalex.org/W2040691054","https://openalex.org/W2042362356","https://openalex.org/W2070110264","https://openalex.org/W2107821023","https://openalex.org/W2121448896","https://openalex.org/W2124613235","https://openalex.org/W2136060128","https://openalex.org/W2145442626","https://openalex.org/W2161120899","https://openalex.org/W2166422945","https://openalex.org/W2266798908","https://openalex.org/W2807855415"],"related_works":["https://openalex.org/W2121448896","https://openalex.org/W2089849103","https://openalex.org/W2912914929","https://openalex.org/W1979708462","https://openalex.org/W2371303488","https://openalex.org/W2370751518","https://openalex.org/W2031132161","https://openalex.org/W1996622616","https://openalex.org/W2514996855","https://openalex.org/W2811244860"],"abstract_inverted_index":{"Spleen":[0],"tyrosine":[1],"kinase":[2],"(SYK)":[3],"is":[4],"one":[5],"of":[6,19,29,66,81,99,107,123],"the":[7,30,34,53,57,78,100,105,108,121],"more":[8],"advanced":[9],"small-molecule":[10],"targets":[11],"with":[12,68,77],"regard":[13],"to":[14,41],"clinical":[15],"development":[16],"for":[17,117],"treatment":[18],"inflammatory":[20],"diseases.":[21],"In":[22,56],"this":[23],"review":[24],"we":[25],"continue":[26],"our":[27],"analysis":[28,39],"patent":[31,102],"literature":[32,103],"covering":[33],"time":[35],"period":[36],"2011-2013.":[37],"The":[38],"relates":[40],"any":[42],"organization":[43],"that":[44,48],"has":[45,62],"filed":[46],"applications":[47,85],"explicitly":[49],"discloses":[50],"SYK":[51,101,124],"as":[52],"intended":[54],"target.":[55],"last":[58],"2":[59],"years":[60],"there":[61],"been":[63],"a":[64,69,74,87],"surge":[65],"application":[67],"few":[70],"new":[71],"entries":[72],"in":[73,83,120],"crowded":[75],"field":[76],"structural":[79],"theme":[80],"compounds":[82],"these":[84],"being":[86],"traditional":[88],"type":[89],"I":[90],"ATP":[91],"competitive":[92],"inhibitor":[93],"[":[94],"1":[95],"].":[96],"This":[97],"overview":[98],"and":[104],"learning's":[106],"inhibitors":[109],"substitution":[110],"patterns":[111],"would":[112],"be":[113],"an":[114],"important":[115],"reading":[116],"anyone":[118],"working":[119],"area":[122],"inhibitors.":[125]},"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":1}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}